An examination study of the methods for evaluating the effects of subjective symptoms by consuming the test food in Japanese subjects with knee pain or discomfort: a randomized, open-labeled study - An examination study of the methods for evaluating the effects of subjective symptoms by consuming the test food in Japanese subjects with knee pain or discomfort

ORTHOMEDICO Inc.0 sites32 target enrollmentJuly 27, 2022

Overview

Phase: 未知
Intervention: Not specified
Conditions: Not specified
Sponsor: ORTHOMEDICO Inc.
Enrollment: 32
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

July 27, 2022

End Date

December 15, 2022

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

ORTHOMEDICO Inc.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Subjects (who/whose) 1\.are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\.have pacemaker or an implantable cardioverter defibrillator 3\.are undergoing medical treatment or have a medical history for chronic disease such as arrhythmia, hepatopathy, nephropathy, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, or hyperuricemia 4\.have undergone or need to undergo joint surgery 5\.have undergone intra\-articular injections (e.g. hyaluronic acid or steroid) within a year before the agreement to participate, or who need to undergo them during this trial 6\.have a history of markedly abnormal in laboratory values or cardiopulmonary function 7\.intensely exercise with excessive load on joints 8\.have a medical history of diseases associated with bone or joint such as fracture, sprain, arthritis, or periarthritis within a year before the agreement to participate 9\.use a cane or joint support, or may use them during this trial 10\.laboratory or measured values markedly deviate from the reference values at Scr 11\.are judged as ineligible to participate based on a background investigation 12\.usually use "Foods for Specified Health Uses," or "Foods with Functional Claims" {e.g. N\-acetylglucosamine, proteoglycan from salmon nasal cartilage (SNC), undenatured type II collagen from SNC, glucosamine hydrochloride, curcumin, elastin peptide from skipjack, or collagen peptide} 13\.currently taking medications (including herbal medicines) 14\.are allergic to medicines or the test food related products 15\.are pregnant or lactating / plan to become pregnant during this trial 16\.have or are strongly suspected to have an infectious disease such as COVID\-19 17\.have been enrolled in other clinical trials within the last 28 days before the agreement to participate or plan to participate another trial during this trial 18\.are judged as ineligible to participate by the principle investigational doctor